Safety Considerations in Phase 1 Trials - PowerPoint Presentation

349 views
Uploaded On 2018-12-07

Safety Considerations in Phase 1 Trials - PPT Presentation

Sumathi Nambiar MD MPH Director Division of AntiInfective Products November 7 2016 Outline General considerations with clinical trials early in development Predictable and unpredictable adverse reactions ID: 737950

safety dose toxicity adverse dose safety adverse toxicity studies clinical trials toxicities considerations animal factor species duration starting class

Link:

Copy

Embed:

<iframe width="560" height="315" src="https://www.docslides.com/embed/737950" frameborder="0" allowfullscreen></iframe>

Download Presentation from below link

Download Presentation The PPT/PDF document "Safety Considerations in Phase 1 Trials" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.